Immunohistochemical investigation of migration inhibitory factor-related protein (MRP)-14 expression in

K Arai1, T Yamada, R Nozawa

  • 1Department of Pathology, Shizuoka General Hospital, Kitaando, Shizuoka, Japan.

Insights

Migration inhibitory factor-related protein (MRP)-14 is newly expressed in hepatocellular carcinoma (HCC), particularly in poorly differentiated tumors. Its expression correlates with tumor grade but not vascular invasion in HCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunohistochemistry

Background:

  • Migration inhibitory factor-related protein (MRP)-8 and -14 are S-100 proteins involved in myeloid cell differentiation and expressed in some epithelia.
  • Limited research exists on MRP expression in carcinomas, necessitating further investigation.

Purpose of the Study:

  • To evaluate MRP-14 expression in hepatocellular carcinoma (HCC) using immunohistochemistry.
  • To examine the relationship between MRP-14 expression, tumor differentiation, and vascular invasion in HCC.

Main Methods:

  • Immunohistochemical evaluation of MRP-14 expression in 70 HCC cases using the monoclonal antibody 60B8.
  • Correlation analysis of MRP-14 expression with Edmondson-Steiner tumor differentiation grades and vascular invasion status.

Main Results:

  • MRP-14 was expressed in 32 out of 70 HCC cases, predominantly in grade II and grade III tumors.
  • Significantly higher MRP-14 expression was observed in grade III HCC compared to grade II.
  • No MRP-14 immunopositivity was detected in non-carcinomatous hepatocytes or bile duct epithelia.
  • MRP-14 expression was also more pronounced in poorly differentiated cholangiocellular carcinoma and metastatic adenocarcinoma.
  • MRP-14 expression rate in HCC with vascular invasion (56%) showed no significant difference from non-invasive tumors.

Conclusions:

  • Malignant hepatocytes exhibit neo-expression of MRP-14.
  • MRP-14 neo-expression in HCC correlates with tumor differentiation, being higher in poorly differentiated carcinomas.
  • MRP-14 is frequently neo-expressed in poorly differentiated carcinomas, including HCC, cholangiocellular carcinoma, and metastatic adenocarcinoma.

Related Concept Videos